الصفحة الرئيسية>>Signaling Pathways>> Microbiology & Virology>> Influenza virus>>Sodium copper chlorophyllin

Sodium copper chlorophyllin

رقم الكتالوجGC32192

يمارس كلوروفيللين نحاس الصوديوم أنشطة مضادة للفيروسات ضد فيروس الأنفلونزا وفيروس نقص المناعة البشرية مع نسبة 50 إلى 100 من 50 إلى 100 μ ؛ M لكليهما.

Products are for research use only. Not for human use. We do not sell to patients.

Sodium copper chlorophyllin التركيب الكيميائي

Cas No.: 28302-36-5

الحجم السعر المخزون الكميّة
1g
46٫00
متوفر
10mM (in 1mL Water)
50٫00
متوفر

Tel:(909) 407-4943 Email: sales@glpbio.com

مراجعات العميل

بناء على آراء العملاء.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Protocol Chemical Properties Product Documents Related Products

Sodium copper chlorophyllin exerts antiviral activities against Influenza virus and HIV with IC50s of 50 to 100 μM for both of them.

Sodium copper chlorophyllin exhibits influenza virus adsorption at 200 µM (P<0.05). The 50% inhibitory concentration (IC50) and the 50% cytotoxic concentration (CC50) of Sodium copper chlorophyllin lay from 50 to 100 µM and 200 to 400 µM, respectively. Sodium copper chlorophyllin also inhibits HIV adsorption at 2.5 mM (P<0.05). The IC50 and CC50 of Sodium copper chlorophyllin lay from 50 to 100 µM and 200 to 400 µM, respectively[1].

[1]. Akiko Ito, et al. In Vitro Inhibition of Cytopathic Effect of Influenza Virus and Human Immunodeficiency Virus by Bamboo Leaf Extract Solution and Sodium Copper Chlorophyllin. Yonago Acta Med. 2016 Mar; 59(1): 61-65.

مراجعات

Review for Sodium copper chlorophyllin

Average Rating: 5 ★★★★★ (Based on Reviews and 23 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Sodium copper chlorophyllin

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.